Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Dyne Therapeutics Inc (NQ: DYN ) 42.86 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Dyne Therapeutics Inc < Previous 1 2 3 Next > XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details July 14, 2024 10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit... Via Benzinga Chart Of The Day: Dyne Therapeutics - Deeply Discounted July 10, 2024 Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United... Via Talk Markets Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday June 12, 2024 Via Benzinga Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React June 12, 2024 U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cut in September. Via Benzinga Topics Economy Exposures Interest Rates Recap: Dyne Therapeutics Q4 Earnings March 05, 2024 Via Benzinga The 3 Most Undervalued Biotech Stocks to Buy in June 2024 June 04, 2024 https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate Via InvestorPlace Modine Manufacturing Posts Mixed Q4 Results, Joins Viasat, Lululemon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session May 22, 2024 Via Benzinga Why Is Dyne Therapeutics Stock Soaring On Monday? May 20, 2024 Dyne Therapeutics reported promising Phase 1/2 trial data for DYNE-101 in myotonic dystrophy type 1 and DYNE-251 in Duchenne muscular dystrophy. Improvements in splicing correction, myotonia, muscle... Via Benzinga Tech Surge Boosts Nasdaq To Record Highs May 20, 2024 The Nasdaq Composite Index is up triple digits and marking new record highs, thanks to rising tech stocks. Via Talk Markets Topics Stocks Exposures US Equities Why Dyne Therapeutics, With A 108% Run This Year, Just Catapulted Again May 20, 2024 Dyne Therapeutics is looking to take on Sarepta Therapeutics in DMD. Via Investor's Business Daily Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday May 20, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday May 20, 2024 Pre-market stock movers are a great way to start the trading week and we have all of the hottest news worth reading about on Monday! Via InvestorPlace DYN Stock Earnings: Dyne Therapeutics Misses EPS for Q1 2024 May 02, 2024 DYN stock results show that Dyne Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday March 25, 2024 U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday. Via Benzinga Topics Stocks Exposures US Equities Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 25, 2024 Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. Via Benzinga Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge March 14, 2024 Cantor Fitzgerald initiates coverage on Avidity Biosciences highlighting a robust pipeline led by del-desiran, a promising treatment for Myotonic dystrophy type 1. With strong management, proven... Via Benzinga Chardan Capital Maintains Buy Rating for Dyne Therapeutics: Here's What You Need To Know March 08, 2024 Via Benzinga Piper Sandler Maintains Overweight Rating for Dyne Therapeutics: Here's What You Need To Know March 06, 2024 Via Benzinga DYN Stock Earnings: Dyne Therapeutics Misses EPS for Q4 2023 March 05, 2024 DYN stock results show that Dyne Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday March 01, 2024 U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday. Via Benzinga Topics Stocks Exposures US Equities Top 4 Health Care Stocks You May Want To Dump In February February 15, 2024 As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. Via Benzinga 7 Speculative Stocks to Double Your Money THIS Year January 22, 2024 Although terribly risky, these stocks to double your money could be enticing if you have some pocket change lying around. Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session January 15, 2024 Via Benzinga $30M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying January 12, 2024 Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades. Via Benzinga Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 05, 2024 Shares of Applied Therapeutics, Inc. Via Benzinga Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session January 05, 2024 U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on Friday. Via Benzinga Topics Stocks Exposures US Equities Crude Oil Moves Lower; Walgreens Posts Upbeat Earnings January 04, 2024 U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining over 100 points on Thursday. The Dow traded up 0.33% to 37,554.56 while the NASDAQ fell 0.10% to 14,578.04. The S&P... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session January 04, 2024 Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.< Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session January 04, 2024 Via Benzinga Dow Surges 200 Points; US Services PMI Edges Higher In December January 04, 2024 U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 200 points on Thursday. The Dow traded up 0.55% to 37,635.05 while the NASDAQ rose 0.05% to 14,599.10.... Via Benzinga Topics Stocks Exposures US Equities < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.